Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Enferm. clín. (Ed. impr.) ; 30(2): 82-88, mar.-abr. 2020. graf
Artigo em Espanhol | IBECS-Express | ID: ibc-FGT-3070

RESUMO

Objetivo: Evaluar la efectividad clínica y la rentabilidad del sistema de monitorización flash con FreeStyle Libre(R) versus la monitorización tradicional en pacientes con diabetes mellitus tipo 1 en el Área de Salud de Burgos (España) por medio de la comparación del gasto en recursos materiales utilizados para la monitorización de la glucemia antes y después de la utilización de este sistema. Método: Se realiza un estudio descriptivo transversal, ambispectivo, para comparar los costes y la efectividad entre dos formas de control de glucemia. La información se obtiene de la historia clínica informatizada (Medora) y por referencia del paciente; se analiza un año pre- y un año pos-FreeStyle Libre(R) el material para la monitorización y las variables clínicas de control glucémico (HbA1c y eventos de hipoglucemia [< 70 mg/dl] sintomática). Resultados: Se incluyen 23 pacientes con diabetes mellitus tipo 1 de 35,4 (± 15,1) años de edad (60,9% varones). La monitorización por el sistema FreeStyle Libre(R) tiene un coste anual medio por paciente 4 veces mayor que el método tradicional. El nivel de HbA1c se reduce un 5% (p = 0,024) y la tasa de hipoglucemias sintomáticas baja un 58,9% (p = 0,013). Esto determina una efectividad en la reducción absoluta de riesgo de 0,232 (23,2%) a nivel de hipoglucemias y un coste-efectividad incremental de 6.194,71 €. Conclusiones: El sistema FreeStyle Libre(R) presenta una efectividad clínica elevada asociada a un coste alto potencialmente aceptable para la monitorización de la glucemia en la diabetes mellitus tipo 1


Objective: This study seeks to evaluate the clinical effectiveness and cost-effectiveness of FreeStyle Libre (R) versus traditional monitoring in patients with type 1 diabetes mellitus in the Health Area of Burgos (Spain). Method: A transversal ambispective descriptive study was carried out to compare costs and effectiveness between two forms of glycaemic control. The information was obtained from the computerized clinical history (Medora) and by referring to patients. An analysis of the monitoring material and clinical glycaemic control variables (HbA1c and symptomatic hypoglycaemia events, < 70 mg/dL) were carried out one year before and one year after the start of FreeStyle Libre(R). Results: We included 23 patients with type 1 diabetes mellitus of 35.4 (± 15.1) years old (60.9% males). Monitoring by FreeStyle Libre(R) system has an average annual cost per patient four times higher than the traditional method. The HbA1c level was reduced by 5% (P= .024) and the rate of symptomatic hypoglycaemia decreased by 58.9% (P = .013). This determines an effectiveness in the absolute risk reduction of .232 (23.2%) of hypoglycaemia and an incremental cost-effectiveness of € 6,194.71. Conclusions: The FreeStyle Libre(R) system has a high clinical effectiveness associated with a high but potentially acceptable cost for glycaemia monitoring in type 1 diabetes mellitus

2.
Enferm Clin ; 2019 Sep 03.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-31492523

RESUMO

OBJECTIVE: This study seeks to evaluate the clinical effectiveness and cost-effectiveness of FreeStyle Libre® versus traditional monitoring in patients with type 1 diabetes mellitus in the Health Area of Burgos (Spain). METHOD: A transversal ambispective descriptive study was carried out to compare costs and effectiveness between two forms of glycaemic control. The information was obtained from the computerized clinical history (Medora) and by referring to patients. An analysis of the monitoring material and clinical glycaemic control variables (HbA1c and symptomatic hypoglycaemia events, <70mg/dL) were carried out one year before and one year after the start of FreeStyle Libre®. RESULTS: We included 23 patients with type 1 diabetes mellitus of 35.4 (± 15.1) years old (60.9% males). Monitoring by FreeStyle Libre® system has an average annual cost per patient four times higher than the traditional method. The HbA1c level was reduced by 5% (P=.024) and the rate of symptomatic hypoglycaemia decreased by 58.9% (P=.013). This determines an effectiveness in the absolute risk reduction of .232 (23.2%) of hypoglycaemia and an incremental cost-effectiveness of €6,194.71. CONCLUSIONS: The FreeStyle Libre® system has a high clinical effectiveness associated with a high but potentially acceptable cost for glycaemia monitoring in type 1 diabetes mellitus.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA